Announcements

We are pleased to share a selection of papers from the 2024 collection on the topic “Advances and Challenges in the Precision Management of Breast Cancer”, published in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.

1. “Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions”
by Rohan Kalyan Rej, Joyeeta Roy and Srinivasa Rao Allu
Cancers 2024, 16(3), 552; https://doi.org/10.3390/cancers16030552
Available online: https://www.mdpi.com/2072-6694/16/3/552

2. “Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond”
by Virginia Valentini, Agostino Bucalo, Giulia Conti, Ludovica Celli, Virginia Porzio, Carlo Capalbo, Valentina Silvestri and Laura Ottini
Cancers 2024, 16(3), 579; https://doi.org/10.3390/cancers16030579
Available online: https://www.mdpi.com/2072-6694/16/3/579

3. “The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy”
by Corrado Tinterri, Bethania Fernandes, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino et al.
Cancers 2024, 16(2), 376; https://doi.org/10.3390/cancers16020376
Available online: https://www.mdpi.com/2072-6694/16/2/376

4. “Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer”
by Natalia Andryszak, Daria Świniuch, Elżbieta Wójcik, Rodryg Ramlau, Marek Ruchała and Rafał Czepczyński
Cancers 2024, 16(3), 667; https://doi.org/10.3390/cancers16030667
Available online: https://www.mdpi.com/2072-6694/16/3/667

5. “De-Escalation Surgery in cT3-4 Breast Cancer Patients after Neoadjuvant Therapy: Predictors of Breast Conservation and Comparison of Long-Term Oncological Outcomes with Mastectomy”
by Corrado Tinterri, Erika Barbieri, Andrea Sagona, Alberto Bottini, Giuseppe Canavese and Damiano Gentile
Cancers 2024, 16(6), 1169; https://doi.org/10.3390/cancers16061169
Available online: https://www.mdpi.com/2072-6694/16/6/1169

6. “High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer”
by Minna M. Jääskeläinen, Ritva Tumelius, Kirsi Hämäläinen, Kirsi Rilla, Sanna Oikari, Aino Rönkä, Tuomas Selander, Arto Mannermaa, Satu Tiainen and Päivi Auvinen
Cancers 2024, 16(3), 634; https://doi.org/10.3390/cancers16030634
Available online: https://www.mdpi.com/2072-6694/16/3/634

7. “Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets”
by Amalia Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos and Azadeh Nasrazadani
Cancers 2024, 16(6), 1139; https://doi.org/10.3390/cancers16061139
Available online: https://www.mdpi.com/2072-6694/16/6/1139

8. “Systemic and Local Strategies for Primary Prevention of Breast Cancer”
by Erin K. Zaluzec and Lorenzo F. Sempere
Cancers 2024, 16(2), 248; https://doi.org/10.3390/cancers16020248
Available online: https://www.mdpi.com/2072-6694/16/2/248

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cancers (ISSN: 2072-6694) recognizes the significant role that our reviewers play in maintaining the quality and integrity of the articles that we publish. According to surveys conducted in 2024, 92% of our authors rate the peer-review process as good or excellent, which is thanks to our pool of excellent reviewers.

We wish to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist Cancers’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback and contributing to academic rigor, are truly commendable.

The Exceptional Reviewers List was introduced in April 2025. Each quarter, we select a group of outstanding reviewers, and we introduce them here.

Q1
Name: Dr. Mohammad Mofatteh
Affiliation: School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast, UK
Interests: neurosurgery; surgery; neuroscience; global health; medical education
“Engaging in peer-review sharpens my critical thinking, keeps me at the forefront of cutting-edge research, and strengthens the scientific community by ensuring rigorous quality assurance. I prioritize delivering constructive feedback to elevate the clarity, validity, and impact of each manuscript.”

Name: Dr. Radu O. Minea
Affiliation: Department of Neurosurgery, Keck School of Medicine, USC, Los Angeles, CA 90089, USA
Interests: cancer biology; apoptosis; cell culture; cell signaling; cancer cell biology; cell proliferation; flow cytometry; gene expression; immunohistochemistry; Western blot analysis
“I have enjoyed working with the editors of the Cancers journal in my past interactions with them and I am committed to help with the peer-review process in the future.”

Name: Dr. Radoslaw Pach
Affiliation: Jagiellonian University Medical College, Krakow, Poland
Interests: oncological surgery; colorectal cancer; gastric cancer; thyroid surgery; hernia; laparoscopy
“I review for journals using my clinical and research expertise to assess oncology studies, focusing on rigor, clarity, and impact, and providing constructive, evidence-based feedback.”

Name: Dr. Giovanni Colonna
Affiliation: Medical Informatics Unit, AOU L. Vanvitelli, University of Campania, Piazzetta Sant’Aniello a Caponapoli 2, 80138 Naples, Italy
Interests: cancer biology; bioinformatics and computational biology; enzymes; proteins; PCR;
protein purification; protein expression; evolution; critical thinking; cancer cell biology
“Cancer research faces significant obstacles in accurately modeling the complexity of human tumors with current preclinical systems. From observational data, we cannot directly obtain the deep molecular causes without specific experimental data.”

Name: Prof. Dr. Lars Martin Wagner
Affiliation: Division of Pediatric Hematology/Oncology, Duke University, Durham, North Carolina
Interests: pediatric sarcoma; young adult sarcoma; clinical trials; sarcoma biology; treatment response; rare cancers; translational research

World Immunization Week, celebrated annually during the last week of April, is a global health awareness initiative highlighting the critical role of vaccines in protecting people of all ages against vaccine-preventable diseases.

On this momentous occasion, we are thrilled to present a thoughtfully selected compilation of articles and Special Issues that focus on the pioneering research and cutting-edge strategies in immunology and vaccination. We encourage readers to delve into these scholarly contributions and stand with us in our commitment to preserving and enhancing global immunization health.

Join us as we explore the latest findings and innovative methods that are shaping the future of immunization. Together, we can strive towards a world where every individual has access to the life-saving benefits of vaccines.

We hope that the established journals in the fields of biology life sciences and medicine and pharmacology at MDPI will provide a communication platform for innovative ideas regarding prevention and treatment.

“Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine”
by Anthie Damianaki, Antonios Marmarinos, Margaritis Avgeris, Dimitrios Gourgiotis, Elpis-Athina Vlachopapadopoulou, Marietta Charakida, Maria Tsolia and Lydia Kossiva
Diseases 2025, 13(3), 78; https://doi.org/10.3390/diseases13030078

“Evaluating the Potential of Herbal Extracts as Treatment in Immune Thrombocytopenia: A Review of Evidence and Limitations”
by Russell W. Wiggins, Jihoo Woo, John Nicholas Cauba and Shizue Mito
Appl. Biosci. 2025, 4(1), 1; https://doi.org/10.3390/applbiosci4010001

“Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives”
by Ilaria Salvato and Antonio Marchini
Cancers 2024, 16(7), 1276; https://doi.org/10.3390/cancers16071276

“Unveiling Extramedullary Hematopoiesis: A Case Report Highlighting the Causes, Symptoms, and Management Strategies”
by Konstantinos Manganas, Aikaterini Xydaki, Angeliki Kotsiafti, Olympia Papakonstantinou and Sophia Delicou
Thalass. Rep. 2024, 14(2), 26-32; https://doi.org/10.3390/thalassrep14020004

“Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches”
by Natalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, Katarzyna Kuncewicz and Moustafa Gabr
J. Pers. Med. 2024, 14(1), 68; https://doi.org/10.3390/jpm14010068

“Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders”
by Yi Zhang, Anna-Lise Bissola, Jared Treverton, Michael Hack, Mark Lychacz, Sarah Kwok, Addi Arnold and Ishac Nazy
J. Clin. Med. 2024, 13(4), 1012; https://doi.org/10.3390/jcm13041012

“Immune Response to Respiratory Viral Infections”
by Antonella Gambadauro, Francesca Galletta, Alessandra Li Pomi, Sara Manti and Giovanni Piedimonte
Int. J. Mol. Sci. 2024, 25(11), 6178; https://doi.org/10.3390/ijms25116178

“Neutrophil Extracellular DNA Traps in Response to Infection or Inflammation, and the Roles of Platelet Interactions”
by William A. Chen and Danilo S. Boskovic
Int. J. Mol. Sci. 2024, 25(5), 3025; https://doi.org/10.3390/ijms25053025

“Host Immune Regulation in Implant-Associated Infection (IAI): What Does the Current Evidence Provide Us to Prevent or Treat IAI?”
by Zulipikaer Maimaiti, Zhuo Li, Chi Xu, Jun Fu, Li-Bo Hao, Ji-Ying Chen and Wei Chai
Bioengineering 2023, 10(3), 356; https://doi.org/10.3390/bioengineering10030356

“Airborne Pollen Calendar of Toluca City, Mexico”
by Maria Cid del Prado, Osvaldo Zarco-Cid del Prado, Hilda Adriana Guerrero-Parra and Karla Elisa Juárez Contreras
Aerobiology 2023, 1(1), 54-69; https://doi.org/10.3390/aerobiology1010005

“Innovative Therapies and Management of Complications in Hemoglobinopathies”	“Peptide-Based Vaccines: An Efficient Alternative to Combat Infectious Diseases and Drug Resistance”
“Immunotherapy in the Management of Hematologic Malignancy”	“Feature Review for Applied Biosciences”
“Advances in Transfusion Medicine and Immunological Research”	“Advancements in Artificial Intelligence for Bioaerosol Detection, Characterization, and Modeling”

We are pleased to announce that seven new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694), joining in February 2025. We wish our new members success in both their research and their efforts to develop the journal.

Name: Prof. Dr. Muy-Teck Teh
Affiliation: ¹ Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts; ² The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Interests: molecular diagnostics; cancer biomarkers; transcriptomics; foxm1; qmids digital cancer test

Name: Prof. Dr. Thomas Ming Swi Chang
Affiliation: ¹ Artificial Cells and Organs Research Centre, Faculty of Medicine and Medical Sciences; ² McGill University, Montreal, QC H3G1Y6, Canada
Interests: artificial cells; biomaterials; blood substitutes; drug delivery; microencapsulation; enzyme engineering

Name: Dr. Dario Baratti
Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Interests: hyperthermic intraperitoneal chemotherapy; cytoreductive surgery; peritoneum tumor; peritoneal malignancies; colorectal cancer

Name: Dr. Chiara Laezza
Affiliation: Consiglio Nazionale delle Ricerche, IEOS, CNR, 80145 Naples, Italy
Interests: mevalonate pathway; prenylation proteins; cannabinoid and cancer; cell cycle; cancer-related biochemical pathways; cell proliferation; cell signaling; breast cancer; glioblastoma multiforme

Name: Prof. Dr. Cesare Gridelli
Affiliation: Division of Medical Oncology, S.G. Moscati Hospital, 83100 Avellino, Italy
Interests: lung cancer; non-small cell lung cancer; targeted therapies; immunotherapy

Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.

Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files:

• A full academic CV;
• A short cover letter detailing your interest in the position.

World Health Day aims to draw global attention to pressing health challenges, reinforcing our commitment to the United Nations’ Sustainable Development Goal 3—ensuring healthy lives and promoting well-being for all.

This year’s theme, “Healthy Beginnings, Hopeful Futures” highlights the importance of maternal and infant health. Current estimates show that a woman dies every two minutes from preventable causes related to pregnancy and childbirth. Urgent action is needed to end preventable maternal and newborn deaths and to prioritize women’s long-term health and well-being.

To provide high-quality care before, during, and after childbirth, we must engage in critical discussions and foster collaboration among researchers, policymakers, and healthcare professionals. Health systems must evolve to address the full spectrum of maternal and newborn health issues—from obstetric complications to mental health conditions, noncommunicable diseases, and family planning.

In recognition of World Health Day 2025, we invite you to explore a curated selection of articles, journals, and Special Issues spanning multiple disciplines. These resources offer valuable insights into the complexities of maternal and infant health and outline actionable steps toward lasting, positive change.

Together, we can build a world where every mother and child have the opportunity for a healthy, hopeful future.

Maternal Health
“Relationship Between Plasma Acid Sphingomyelinase and Alteration in Taste and Smell as Indicator of Long COVID in Pregnant Women”
by Federico Fiorani, Giulia Moretti, Laura Cerquiglini, Chiara Gizzi, Giulia Gizzi, Paola Signorelli, Samuela Cataldi, Tommaso Beccari, Elisa Delvecchio, Claudia Mazzeschi et al.
Reports 2024, 7(4), 104; https://doi.org/10.3390/reports7040104
  
“Pregnant Women’s Perception of Gestational Anemia and Iron Supplements in Oman”
by Zalikha Khamis Al-Marzouqi, Nawal Said Alsereahi and Safiya Khalfan Al Maqbali
J. Oman Med. Assoc. 2024, 1(1), 10–22; https://doi.org/10.3390/joma1010003

“The Sri Lanka Mother and Newborn Growth (S-MaNGro) Cohort: Protocol of a Nationwide Prospective Study”
by Malshani Lakshika Pathirathna, Megumi Haruna, Satoshi Sasaki, Kaori Yonezawa, Yuriko Usui and Yasuhiro Hagiwara
Methods Protoc. 2024, 7(4), 61; https://doi.org/10.3390/mps7040061

“Gestational Trophoblastic Disease: Complete versus Partial Hydatidiform Moles”
by Jeffrey Gonzalez, Meagan Popp, Stephanie Ocejo, Alvaro Abreu, Hisham F. Bahmad and Robert Poppiti
Diseases 2024, 12(7), 159; https://doi.org/10.3390/diseases12070159

“Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective”
by Lucia Stančiaková, Kristína Brisudová, Ingrid Škorňová, Tomáš Bolek, Matej Samoš, Kamil Biringer, Ján Staško and Juraj Sokol
Pharmaceuticals 2024, 17(6), 773; https://doi.org/10.3390/ph17060773

“Caring for Pregnant Patients with Cancer: A Framework for Ethical and Patient-Centred Care”
by Alma Linkeviciute, Rita Canario, Fedro Alessandro Peccatori and Kris Dierickx
Cancers 2024, 16(2), 455; https://doi.org/10.3390/cancers16020455

“Histopathological Clues of Enhanced Inflammation in the Placental Tissue of Women with Chronic Venous Disease in Lower Limbs during Pregnancy”
by María Asunción Sánchez-Gil, Oscar Fraile-Martinez, Cielo García-Montero, María Del Val Toledo, Luis G. Guijarro, Juan A. De León-Luis, Coral Bravo, Raúl Díaz-Pedrero, Laura López-Gonzalez, Miguel A. Saez et al.
J. Pers. Med. 2024, 14(1), 87; https://doi.org/10.3390/jpm14010087

“Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project”
by Martje Van Neste, Annick Bogaerts, Nina Nauwelaerts, Julia Macente, Anne Smits, Pieter Annaert and Karel Allegaert
Pharmaceutics 2023, 15(11), 2618; https://doi.org/10.3390/pharmaceutics15112618

“Umbilical Cord Diseases Affecting Obstetric and Perinatal Outcomes”
by Gabriele Tonni, Mario Lituania, Alessandro Cecchi, Elisa Carboni, Serena Resta, Maria Paola Bonasoni and Rodrigo Ruano
Healthcare 2023, 11(19), 2634; https://doi.org/10.3390/healthcare11192634

“Scientists’ Warning: Remove the Barriers to Contraception Access, for Health of Women and the Planet”
by Jan Greguš and John Guillebaud
World 2023, 4(3), 589–597; https://doi.org/10.3390/world4030036

“Trauma-Informed Care and Equity in Group Pregnancy Care for Women of Refugee Background: Reflections from the Workforce”
by Fran Hearn, Laura Biggs, Stephanie J. Brown, Ann Krastev, Josef Szwarc and Elisha Riggs
Trauma Care 2023, 3(3), 161–176; https://doi.org/10.3390/traumacare3030016

“Smoking Cessation Rates among Pregnant Women and Their Relapse Rates in the Postpartum Period in Samsun”
by Bektas Murat Yalcin, Tugba Kertmen and Muge Ustaoglu
J. Respir. 2023, 3(3), 118–129; https://doi.org/10.3390/jor3030012

“Effects of COVID-19 on Kenya’s Healthcare System: Healthcare Providers’ Experiences with Maternal Health Services Utilization in Coastal Kenya”
by Stephen Okumu Ombere and Agnetta Adiedo Nyabundi
World 2023, 4(1), 140–152; https://doi.org/10.3390/world4010010

Infant and Child Health
“Clinical Insight into Congenital Hypothyroidism Among Children”
by Hüseyin Anıl Korkmaz
Children 2025, 12(1), 55; https://doi.org/10.3390/children12010055

“Child and Adolescent Mental Health in a Period of Fewer COVID-19-Related Restrictions in an Urban Population in Germany”
by Anna Konopka, Amand Führer, Mascha Binder, Sophie Diexer, Thomas Frese, Michael Gekle, Matthias Girndt, Cornelia Gottschick, Jessica Hoell, Bianca Klee et al.
Psychiatry Int. 2024, 5(4), 718–737; https://doi.org/10.3390/psychiatryint5040050

“Differences in Farmers’ Market Patronage among Participants in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)”
by Renata Blumberg, Emily Fowler, Gabrielle Guerrero, Yeon Bai, Meena Mahadevan and Pankaj Lal
Dietetics 2024, 3(2), 179–190; https://doi.org/10.3390/dietetics3020015

“Maternal Depressive Symptoms in the First Year after Childbirth Predict Long-Term Developmental Risks in Sons and Daughters”
by Linda S. Pagani, Kianoush Harandian, Beatrice Necsa, Marie-Josée Harbec and George M. Tarabulsy
Int. J. Environ. Res. Public Health 2024, 21(3), 264; https://doi.org/10.3390/ijerph21030264

“Inflammatory Biomarker Profiles in Very Preterm Infants within the Context of Preeclampsia, Chorioamnionitis, and Clinically Diagnosed Postnatal Infection”
by Jordan T. Ewald, Baiba Steinbrekera, Jennifer R. Bermick, Donna A. Santillan, Tarah T. Colaizy, Mark K. Santillan and Robert D. Roghair
Pediatr. Rep. 2023, 15(3), 483–493; https://doi.org/10.3390/pediatric15030044

“A Pilot Randomised Controlled Trial Evaluating a Regenerative Epithelial Suspension for Medium-Size Partial-Thickness Burns in Children: The BRACS Trial”
by Anjana Bairagi, Zephanie Tyack, Roy Kimble, Dimitrios Vagenas, Steven M. McPhail and Bronwyn Griffin
Eur. Burn J. 2023, 4(1), 121–141; https://doi.org/10.3390/ebj4010012

“The Impact of the Early COVID-19 Global Pandemic on Children Undergoing Active Cancer Treatment and Their Parents”
by Andrew Tran, Sharon H. J. Hou, Caitlin Forbes, Sara Cho, Victoria J. Forster, Mehak Stokoe, Claire E. Wakefield, Lori Wiener, Lauren C. Heathcote, Gisela Michel et al.
Curr. Oncol. 2023, 30(2), 2441–2456; https://doi.org/10.3390/curroncol30020186

“Feature Advancements in Section “Childhood, Adolescent and Young Adult Oncology””	“Global Neonatal Screening: Expanding Horizons in Diagnostic Technologies”
“Healthy Lifestyle for Pregnant and Postpartum Women”	“Advanced Pediatric Drug Formulation Strategies”

MDPI is pleased to announce our participation in the 62nd ERA Congress, which will be held from 4 to 7 June 2025 in Vienna, Austria.

The 62nd ERA Congress will revolve around the theme of “Game Changers in Nephrology”. The seven main tracks can be explored via the following link: https://www.era-online.org/events/vienna-2025/scientific-programme/.

The following MDPI journals will be represented:

• Kidney and Dialysis;
• Journal of Personalized Medicine;
• Biomedicines;
• Cancers;
• Cells;
• Journal of Clinical Medicine;
• DNA;
• Journal of Molecular Pathology.

If you are attending 62nd ERA Congress, we invite you to visit us at booth X3.380. Our representatives, Mr. Peter Roth and Dr. Jennie Xu, will be available to discuss publishing opportunities, the benefits of open access, and our commitment to advancing geosciences research.

For more information about the conference, please visit its official website: https://www.era-online.org/events/vienna-2025/.

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Pediatric Oncology” Section, which are listed below:

1. “Rhabdomyosarcoma of the Biliary Tract in Children: Analysis of Single Center Experience”
by Ewa Święszkowska, Dorota Broniszczak, Piotr Kaliciński, Marek Szymczak, Marek Stefanowicz, Wiesława Grajkowska and Bożenna Dembowska-Bagińska
Cancers 2024, 16(17), 3110; https://doi.org/10.3390/cancers16173110
Available online: https://www.mdpi.com/2072-6694/16/17/3110

2. “Progress Toward Epigenetic Targeted Therapies for Childhood Cancer”
by Athanasia Liapodimitri, Ashley R. Tetens, Jordyn Craig-Schwartz, Kayleigh Lunsford, Kegan O. Skalitzky and Michael A. Koldobskiy
Cancers 2024, 16(24), 4149; https://doi.org/10.3390/cancers16244149
Available online: https://www.mdpi.com/2072-6694/16/24/4149

3. “Long-Term Outcomes of Childhood Acute Lymphocytic Leukemia Treated with Adapted Berlin–Frankfurt–Münster (BFM) Protocols: A Multicentric Analysis from a Developing Country”
by Patricia Regina Cavalcanti Barbosa Horn, Marilza de Moura Ribeiro-Carvalho, Alice Maria Boulhosa de Azevedo, Adriana Martins de Sousa, Simone Faria, Cristina Wiggers, Soraia Rouxinol, Marcia Trindade Schramm, Bárbara Sarni Sanches, Nathalia Lopez Duarte et al.
Cancers 2024, 16(16), 2898; https://doi.org/10.3390/cancers16162898
Available online: https://www.mdpi.com/2072-6694/16/16/2898

4. “Acute Pancreatitis in Pediatric Acute Lymphoblastic Leukemia (AcuPA Study): A Nationwide Survey in Poland”
by Anna Morawiak, Małgorzata Salamonowicz-Bodzioch, Aleksandra Królak, Krzysztof Kałwak, Joanna Owoc-Lempach, Jerzy Kowalczyk, Joanna Zawitkowska, Tomasz Szczepański, Ninela Irga-Jaworska, Elżbieta Adamkiewicz-Drożyńska et al.
Cancers 2024, 16(15), 2640; https://doi.org/10.3390/cancers16152640
Available online: https://www.mdpi.com/2072-6694/16/15/2640

5. “Efficacy and Safety of Acupuncture and Related Techniques in the Management of Oncological Children and Adolescent Patients: A Systematic Review”
by Esther Martínez García, M. Betina Nishishinya Aquino, Ofelia Cruz Martínez, Yiming Ren, Ruyu Xia, Yutong Fei and Carles Fernández-Jané
Cancers 2024, 16(18), 3197; https://doi.org/10.3390/cancers16183197
Available online: https://www.mdpi.com/2072-6694/16/18/3197

6. “Panobinostat Synergizes with Chemotherapeutic Agents and Improves Efficacy of Standard-of-Care Chemotherapy Combinations in Ewing Sarcoma Cells”
by Kaitlyn H. Smith, Erin M. Trovillion, Chloe Sholler, Divya Gandra, Kimberly Q. McKinney, David Mulama, Karl J. Dykema, Abhinav B. Nagulapally, Javier Oesterheld and Giselle L. Saulnier Sholler
Cancers 2024, 16(21), 3565; https://doi.org/10.3390/cancers16213565
Available online: https://www.mdpi.com/2072-6694/16/21/3565

7. “Characterization of Patient Activation among Childhood Cancer Survivors in the St. Jude Lifetime Cohort Study (SJLIFE)”
by Megan E. Ware, Angelica De La Cruz, Qian Dong, Kyla Shelton, Tara M. Brinkman, I-Chan Huang, Rachel Webster, Brian Potter, Kevin Krull, Sedigheh Mirzaei et al.
Cancers 2024, 16(18), 3220; https://doi.org/10.3390/cancers16183220
Available online: https://www.mdpi.com/2072-6694/16/18/3220

8. “VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma”
by Natalia Muñoz Perez, Juliana M. Pensabene, Phillip M. Galbo, Jr., Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M. Yazejian, Rachel L. Welch, W. Robert Bell, Soma Sengupta et al.
Cancers 2024, 16(15), 2629; https://doi.org/10.3390/cancers16152629
Available online: https://www.mdpi.com/2072-6694/16/15/2629

9. “Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study”
by Stefano Mastrangelo, Giorgio Attinà, Guido Rindi, Alberto Romano, Palma Maurizi and Antonio Ruggiero
Cancers 2024, 16(20), 3440; https://doi.org/10.3390/cancers16203440
Available online: https://www.mdpi.com/2072-6694/16/20/3440

10. “Impaired DNA Double-Strand Break Repair in Irradiated Sheep Lung Fibroblasts: Late Effects of Previous Irradiation of the Spinal Thecal Sac”
by Bassem Youssef, Charbel Feghaly, Joelle Al Choboq, Jolie Bou-Gharios, Rafka Challita, Joyce Azzi, Hanine Bou Hadir, Fabienne Abi Antoun, Tarek Araji, Phillip J. Taddei et al.
Cancers 2024, 16(17), 2968; https://doi.org/10.3390/cancers16172968
Available online: https://www.mdpi.com/2072-6694/16/17/2968

11. “Integrated Psychological Services in Pediatric Oncology: Caregiver Perspectives at Diagnosis”
by Emily Bernstein, Anna M. Jones, Niki Jurbergs, Jennifer L. Harman, Sean Phipps and R. Elyse Heidelberg
Cancers 2024, 16(18), 3137; https://doi.org/10.3390/cancers16183137
Available online: https://www.mdpi.com/2072-6694/16/18/3137

12. “Non-Syndromic and Syndromic Defects in Children with Extracranial Germ Cell Tumors: Data of 2610 Children Registered with the German MAKEI 96/MAHO 98 Registry Compared to the General Population”
by Judit H. Schultewolter, Anke Rissmann, Dietrich von Schweinitz, Michael Frühwald, Claudia Blattmann, Lars Fischer, Björn Sönke Lange, Rüdiger Wessalowski, Birgit Fröhlich, Wolfgang Behnisch et al.
Cancers 2024, 16(11), 2157; https://doi.org/10.3390/cancers16112157
Available online: https://www.mdpi.com/2072-6694/16/11/2157

13. “Telomere Length in Adolescent and Young Adult Survivors of Childhood Cancer”
by Meerim Park, Dong-Eun Lee, Yuna Hong, Jin Kyung Suh, Jun Ah Lee, Myungshin Kim and Hyeon Jin Park
Cancers 2024, 16(13), 2344; https://doi.org/10.3390/cancers16132344
Available online: https://www.mdpi.com/2072-6694/16/13/2344

14. “Rare Oncogenic Fusions in Pediatric Central Nervous System Tumors: A Case Series and Literature Review”
by Melek Ahmed, Anne Sieben, Toon Van Genechten, Sasha Libbrecht, Nathalie Gilis, Mania De Praeter, Christophe Fricx, Pierluigi Calò, Claude Van Campenhout, Nicky D’Haene et al.
Cancers 2024, 16(19), 3344; https://doi.org/10.3390/cancers16193344
Available online: https://www.mdpi.com/2072-6694/16/19/3344

15. “Therapeutic Parent–Child Communication and Health Outcomes in the Childhood Cancer Context: A Scoping Review”
by Heeyeon Son and Nani Kim
Cancers 2024, 16(11), 2152; https://doi.org/10.3390/cancers16112152
Available online: https://www.mdpi.com/2072-6694/16/11/2152

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office

As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the Section “Cancer Drug Development”, which are listed below.

1. “Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer”
by Maria George Elias, Shadma Fatima, Timothy J. Mann, Shawan Karan, Meena Mikhael, Paul de Souza, Christopher P. Gordon, Kieran F. Scott and Janice R. Aldrich-Wright
Cancers 2024, 16(14), 2544; https://doi.org/10.3390/cancers16142544
Available online: https://www.mdpi.com/2072-6694/16/14/2544

2. “A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers”
by Lorenzo Magrassi, Giulia Pinton, Sabino Luzzi, Sergio Comincini, Andrea Scravaglieri, Valentina Gigliotti, Bianca Laura Bernardoni, Ilaria D’Agostino, Francesca Juretich, Concettina La Motta et al.
Cancers 2024, 16(13), 2397; https://doi.org/10.3390/cancers16132397
Available online: https://www.mdpi.com/2072-6694/16/13/2397

3. “Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer”
by Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa et al.
Cancers 2024, 16(14), 2545; https://doi.org/10.3390/cancers16142545
Available online: https://www.mdpi.com/2072-6694/16/14/2545

4. “Dose Optimization of Targeted Therapies for Oncologic Indications”
by Marjorie E. Zettler
Cancers 2024, 16(12), 2180; https://doi.org/10.3390/cancers16122180
Available online: https://www.mdpi.com/2072-6694/16/12/2180

5. “The Anticancer Application of Delivery Systems for Honokiol and Magnolol”
by Katarzyna Dominiak, Aleksandra Gostyńska, Michał Szulc and Maciej Stawny
Cancers 2024, 16(12), 2257; https://doi.org/10.3390/cancers16122257
Available online: https://www.mdpi.com/2072-6694/16/12/2257

6. “Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment”
by Taufeeque Ali, Daniel Li, Thilini Nimasha Fernando Ponnamperumage, Alexis Kimberly Peterson, Jatin Pandey, Kulsum Fatima, John Brzezinski, Julia Anna Rose Jakusz, Hanlun Gao, Gilbert Edward Koelsch et al.
Cancers 2024, 16(12), 2171; https://doi.org/10.3390/cancers16122171
Available online: https://www.mdpi.com/2072-6694/16/12/2171

7. “Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives”
by Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini and Manuela Ferracin
Cancers 2024, 16(15), 2752; https://doi.org/10.3390/cancers16152752
Available online: https://www.mdpi.com/2072-6694/16/15/2752

8. “Antibody-Drug Conjugates in Urothelial Cancer: From Scientific Rationale to Clinical Development”
by Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hyeon Hoe Kim and Min-Kyung Lee
Cancers 2024, 16(13), 2420; https://doi.org/10.3390/cancers16132420
Available online: https://www.mdpi.com/2072-6694/16/13/2420

9. “Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines”
by Nicole Ferrario, Emanuela Marras, Veronica Vivona, Federica Randisi, Antonino Nicolò Fallica, Agostino Marrazzo, Gianpaolo Perletti and Marzia Bruna Gariboldi
Cancers 2024, 16(12), 2227; https://doi.org/10.3390/cancers16122227
Available online: https://www.mdpi.com/2072-6694/16/12/2227

10. “Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review”
by Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, Donal Buggy, Oscar Diaz-Cambronero, Mats Enlund, Patrice Forget, Anil Gupta, Markus W. Hollmann, Daniela Ionescu et al.
Cancers 2024, 16(13), 2304; https://doi.org/10.3390/cancers16132304
Available online: https://www.mdpi.com/2072-6694/16/13/2304

11. “Target-Driven Tissue-Agnostic Drug Approvals—A New Path of Drug Development”
by Kyaw Z. Thein, Yin M. Myat, Byung S. Park, Kalpana Panigrahi and Shivaani Kummar
Cancers 2024, 16(14), 2529; https://doi.org/10.3390/cancers16142529
Available online: https://www.mdpi.com/2072-6694/16/14/2529

12. “Overcoming Chemoresistance in Cancer: The Promise of Crizotinib”
by Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya and Jamal Mahajna
Cancers 2024, 16(13), 2479; https://doi.org/10.3390/cancers16132479
Available online: https://www.mdpi.com/2072-6694/16/13/2479

13. “Molecular Interactions of the Plant Steroid Hormone Epibrassinolide on Human Drug-Sensitive and Drug-Resistant Small-Cell Lung Carcinoma Cells”
by David Sadava and Shiuan Chen
Cancers 2024, 16(22), 3812; https://doi.org/10.3390/cancers16223812
Available online: https://www.mdpi.com/2072-6694/16/22/3812

14. “Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies”
by Christiana Mo, Michelle Sterpi, Hyein Jeon and Fernand Bteich
Cancers 2024, 16(16), 2854; https://doi.org/10.3390/cancers16162854
Available online: https://www.mdpi.com/2072-6694/16/16/2854

15. “Genotoxic and Anti-Migratory Effects of Camptothecin Combined with Celastrol or Resveratrol in Metastatic and Stem-like Cells of Colon Cancer”
by Helena Moreira, Anna Szyjka, Dorota Bęben, Oliwia Siwiela, Anna Radajewska, Nadia Stankiewicz, Małgorzata Grzesiak, Benita Wiatrak, Fathi Emhemmed, Christian D. Muller et al.
Cancers 2024, 16(19), 3279; https://doi.org/10.3390/cancers16193279
Available online: https://www.mdpi.com/2072-6694/16/19/3279

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Tumor Microenvironment” Section, which are listed below:

1. “TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications”
by Chuqi Wang, Jordan Yong Ming Tan, Nishtha Chitkara and Shruti Bhatt
Cancers 2024, 16(17), 3069; https://doi.org/10.3390/cancers16173069
Available online: https://www.mdpi.com/2072-6694/16/17/3069

2. “The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View”
by Federico Mosna
Cancers 2024, 16(13), 2359; https://doi.org/10.3390/cancers16132359
Available online: https://www.mdpi.com/2072-6694/16/13/2359

3. “Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions”
by Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino and Vanessa Desantis
Cancers 2024, 16(13), 2438; https://doi.org/10.3390/cancers16132438
Available online: https://www.mdpi.com/2072-6694/16/13/2438

4. “Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems”
by Dragana Nikitovic, Ekaterina Kukovyakina, Aikaterini Berdiaki, Alexandros Tzanakakis, Anna Luss, Elizaveta Vlaskina, Anne Yagolovich, Aristides Tsatsakis and Andrey Kuskov
Cancers 2024, 16(22), 3768; https://doi.org/10.3390/cancers16223768
Available online: https://www.mdpi.com/2072-6694/16/22/3768

5. “Antibody-Based Therapies for Peripheral T-Cell Lymphoma”
by Nazila Shafagati, Suman Paul, Sima Rozati and Cole H. Sterling
Cancers 2024, 16(20), 3489; https://doi.org/10.3390/cancers16203489
Available online: https://www.mdpi.com/2072-6694/16/20/3489

6. “Importance of Michaelis Constants for Cancer Cell Redox Balance and Lactate Secretion—Revisiting the Warburg Effect”
by Michael Niepmann
Cancers 2024, 16(13), 2290; https://doi.org/10.3390/cancers16132290
Available online: https://www.mdpi.com/2072-6694/16/13/2290

7. “Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance”
by Abdulaziz M. Eshaq, Thomas W. Flanagan, Sofie-Yasmin Hassan, Sara A. Al Asheikh, Waleed A. Al-Amoudi, Simeon Santourlidis, Sarah-Lilly Hassan, Maryam O. Alamodi, Marcelo L. Bendhack, Mohammed O. Alamodi et al.
Cancers 2024, 16(15), 2754; https://doi.org/10.3390/cancers16152754
Available online: https://www.mdpi.com/2072-6694/16/15/2754

8. “Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma”
by Masaki Uchihara, Akiyo Tanabe, Yuki Kojima, Tatsunori Shimoi, Akiko Miyagi Maeshima, Kotaro Umamoto, Akihiko Shimomura, Chikako Shimizu, Yuto Yamazaki, Eijiro Nakamura et al.
Cancers 2024, 16(12), 2191; https://doi.org/10.3390/cancers16122191
Available online: https://www.mdpi.com/2072-6694/16/12/2191

9. “Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies”
by Patrizia Limonta, Raffaella Chiaramonte and Lavinia Casati
Cancers 2024, 16(16), 2861; https://doi.org/10.3390/cancers16162861
Available online: https://www.mdpi.com/2072-6694/16/16/2861

10. “Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component”
by Hubert Pakula, Filippo Pederzoli, Giuseppe Nicolò Fanelli, Pier Vitale Nuzzo, Silvia Rodrigues and Massimo Loda
Cancers 2024, 16(21), 3685; https://doi.org/10.3390/cancers16213685
Available online: https://www.mdpi.com/2072-6694/16/21/3685

11. “A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder”
by Carmen Keim-del Pino, Pablo Ramos-García and Miguel Ángel González-Moles
Cancers 2024, 16(15), 2614; https://doi.org/10.3390/cancers16152614
Available online: https://www.mdpi.com/2072-6694/16/15/2614

12. “Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour”
by Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Joana Assis, Deolinda Pereira and Rui Medeiros
Cancers 2024, 16(13), 2356; https://doi.org/10.3390/cancers16132356
Available online: https://www.mdpi.com/2072-6694/16/13/2356

13. “Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment”
by Anghesom Ghebremedhin, Dipti Athavale, Yanting Zhang, Xiaodan Yao, Curt Balch and Shumei Song
Cancers 2024, 16(19), 3410; https://doi.org/10.3390/cancers16193410
Available online: https://www.mdpi.com/2072-6694/16/19/3410

14 “Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance”
by Shauna McClelland, Pamela J. Maxwell, Cristina Branco, Simon T. Barry, Cath Eberlein and Melissa J. LaBonte
Cancers 2024, 16(16), 2797; https://doi.org/10.3390/cancers16162797
Available online: https://www.mdpi.com/2072-6694/16/16/2797

15. “Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917”
by Georgette A. Radford, Laura Vrbanac, Rebekah T. de Nys, Daniel L. Worthley, Josephine A. Wright, Jeff Hasty and Susan L. Woods
Cancers 2024, 16(17), 2971; https://doi.org/10.3390/cancers16172971
Available online: https://www.mdpi.com/2072-6694/16/17/2971

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office